Discontinued — last reported Q1 '24
Share Repurchase Program - Authorized Amount
EquityEli Lilly Share Repurchase Program - Authorized Amount remained flat by 0.0% to $15.00B in Q3 2025 compared to the prior quarter.
Analysis
StatementBalance Sheet Statement
SectionEquity
First reportedQ1 2020
Last reportedQ1 2024
Metric ID:
share_repurchase_authorization_amountHistorical Data
4 periods
| Q2 '21 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|
| Value | $5.00B | $15.00B | $15.00B | $15.00B |
| QoQ Change | — | +200.0% | +0.0% | +0.0% |
Range$5.00B – $15.00B
Current Streak3+ quarters growth
Share Repurchase Program - Authorized Amount at Other Companies
Frequently Asked Questions
- What is Eli Lilly's share repurchase program - authorized amount?
- Eli Lilly (LLY) reported share repurchase program - authorized amount of $15.00B in Q3 2025.